icon
0%

Universal Health Services Class B UHS - News Analyzed: 2,908 - Last Week: 69 - Last Month: 213

⇗ Universal Health Services Class B UHS Remains Steadfast Amid Trials and Triumphs

Universal Health Services Class B UHS Remains Steadfast Amid Trials and Triumphs
Universal Health Services has faced significant events that have impacted its image in the biotech market. The Cedar Hill Regional Medical Center has been recognized for changing D.C's healthcare industry. Despite a lawsuit filed by more than 100 former patients and accusations of abuse and neglect in their psychiatric hospitals, the company's stocks had a strong Q4, and the forecast indicates growth. A $179,160 stock sale by a UHS director took place alongside continuous investment activities. Multiple outlets consider UHS a good healthcare stock to buy, based on Wall Street estimates and consistent Q4 earnings. Alan B. Miller, the company's founder, stepped down as CEO in January 2021 and remains as Executive Chairman, with Marc D. Miller appointed as the new CEO. UHS faced an enormous loss ($67 million) due to a ransomware attack affecting their IT systems, which they plan to appeal. The Hippocratic AI received funding from various health systems, including UHS. Allegations of misconduct and calls for changes in corporate governance were made, but UHS continues to expand, as demonstrated by significant real estate acquisitions in Palm Beach Gardens.

Universal Health Services Class B UHS News Analytics from Wed, 07 Dec 2016 08:00:00 GMT to Fri, 11 Apr 2025 19:57:03 GMT - Rating 5 - Innovation -3 - Information 3 - Rumor -4

The email address you have entered is invalid.